NCT04241965View on ClinicalTrials.gov

A Single-blind, Placebo-controlled, Outpatient Trial to Assess the Effects of Single Oral Tablet Dose of OPC-214870

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 18, 2020

Primary Completion Date

October 11, 2021

Study Completion Date

October 28, 2021

Conditions

Epilepsy

Interventions

DRUG

OPC-214870

Tablet(s)

OTHER

Placebo

Tablet(s)

Trial Locations (1)

34174

For additional information regarding sites, contact 844-687-8522, Ormond Beach

All Listed Sponsors

lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY

NCT04241965 - A Single-blind, Placebo-controlled, Outpatient Trial to Assess the Effects of Single Oral Tablet Dose of OPC-214870 | Biotech Hunter | Biotech Hunter